| Date | Title | Description |
| 06.08.2024 | The Future of Drug Development: How AI and Advanced Imaging are Shaping the Landscape | In the fast-paced world of drug development, innovation is the lifeblood that keeps the industry moving forward. Two recent advancements illustrate this point vividly: Molecular Devices' launch of the QPix Insights app and Newcells Biotech'... |
| 05.08.2024 | Molecular Devices Launches AI-Powered QPix Insights App for Microbial Colony Picking | QPix Insights enables advanced data analytics and visualization for informed colony selection strategies.
New software enhances data analysis and visualization in automated microbial colony picking
SAN JOSE, Calif., Aug. 5, 2024 /PRNewswire... |
| 01.08.2024 | Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes | Investment in state-of-the-art imaging suite to accelerate data generation with physiologically-relevant in vitro models for deeper insights on drug effects in vivo
Launch of advanced lung FMT assay provides extensive critical efficacy and ... |
| 11.07.2024 | BrightSpec Adds Commercial Firepower to its Leadership Team and Board of Directors | Industry vets Damien Fischer and Tim Germann bring decades of market experience in the life sciences and analytical tools
CHARLOTTESVILLE, Va. and WALTHAM, Mass., July 11, 2024 /PRNewswire/ -- BrightSpec, the market leader in Molecular Rota... |
| 05.06.2024 | Nobel Laureate Professor Sir Martin Evans opens Molecular Devices' Cardiff facility to manufacture patient-derived organoids for research and drug discovery | Plaque unveiled at the formal opening of Molecular Devices’ Cardiff facility that manufactures patient-derived organoids for research and drug discovery.
Molecular Devices is the world's only company offering a service to manufacture standa... |
| 13.03.2024 | Molecular Devices Appoints Mary Duseau as President, Bringing 25 Years of Experience in Life Sciences | Mary Duseau, Molecular Devices President
Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Dusea... |
| 02.11.2023 | Austrian biotech HeartBeat.bio secures €4.5M for cardioid drug discovery platform | Austrian biotech startup HeartBeat.bio has secured a € 4.5 million Pre-Series A round.
The fresh capital will fuel the completion of its cardioid drug discovery platform for proprietary and collaborative drug discovery programs for the like... |
| 20.07.2023 | Molecular Devices launches custom organoid line expansion service using unique bioprocess technology for high-throughput applications | Image of compound treated patient-derived colorectal cancer organoids captured using Molecular Devices' ImageXpress® Confocal HT.ai High-Content Imaging System This unique service will allow researchers to screen thousands to tens of thousa... |
| 22.02.2023 | Silver Sponsor Molecular Devices at Society for Laboratory Automation and Screening 2023 International Conference and Exhibition | We look forward to showcasing how our deep expertise, partnerships, and innovative technologies will open the future of next-generation drug discovery.
SAN JOSE, Calif. (PRWEB) February 22, 2023
Molecular Devices, LLC., a leading provider o... |
| 13.02.2023 | Molecular Devices inks deal with HUB Organoids to advance automated intestinal organoid screening technology | Through this collaboration, we will enable the scale and reproducibility that drug hunters need to confidently participate in a new era of drug discovery and development.
SAN JOSE, Calif. and UTRECHT, Netherlands (PRWEB) February 13, 2023
M... |
| 13.02.2023 | Molecular Devices Inks Deal With Hub Organoids To Advance Automated Intestinal Organoid Screening Technology | Molecular Devices and HUB Organoids collaborate to enable continued development of next-generation 3D biology technologies that drive step-change reduction in pre-clinical to clinical drug attrition.
Molecular Devices, LLC., a leading provi... |
| 07.02.2023 | Molecular Devices partners with SEED Biosciences to exclusively offer DispenCell Single-Cell Dispenser, expanding leadership in cell line development | Integrating the DispenCell Single-Cell Dispenser into our portfolio of automated, end-to-end solutions for cell line development workflows will further strengthen our ability to help the scientific community industrialize biology.
SAN JOSE,... |
| 09.01.2023 | Molecular Devices and Advanced Solutions Life Sciences Collaborate to Develop 3D Biology Automation Technologies for Drug Discovery | Molecular Devices, LLC., a leading provider of high-performance life science solutions, entered into a partnership with Advanced Solutions Life Sciences, LLC (Advanced Solutions), a biofabrication company developing robotic platforms used t... |
| 04.01.2023 | Molecular Devices and Advanced Solutions Life Sciences collaborate to develop 3D Biology Automation Technologies for Drug Discovery | Turnkey platform integrates flexible robotic automation with high-content imaging of complex 3D cellular models, enabling high-volume organoid screening The ImageXpress cellular imaging systems and BAB 400 deliver an automated, turnkey plat... |
| 06.12.2022 | Molecular Devices adds proprietary patient-derived organoid technology with acquisition of Cellesce | First-of-its-kind technology from Cellesce creates consistent patient-derived organoids for large scale drug screening We’re excited to bring our domain expertise and intellectual property to Molecular Devices, together maximizing impact fo... |
| 02.11.2022 | Molecular Devices announces ValitaTiter IgG quantitation assay to fast track biologics sample testing | Using ValitaTiter with our SpectraMax microplate readers, SoftMax Pro Software, and automation solutions further enhances the reliability and reproducibility of assay results and enables seamless integration of the assay in regulated workfl... |
| 14.10.2022 | What is medical artificial intelligence (AI)? | Did you miss a session from MetaBeat 2022? Head over to the on-demand library for all of our featured sessions here.
Table of contents
Risks and rewards
What are the challenges of medical AI?
What are the opportunities for medical AI?
What ... |
| 12.10.2022 | Molecular Devices expands global research and development hub in Austria | From left, Governor Wilfried Haslauer, Molecular Devices President Susan Murphy, Municipal Councilmember Dr. Martin Auer, and Molecular Devices Vice President of Technology Innovation Josef Atzler. “The Organoid Innovation Center – Salzburg... |
| 12.09.2022 | Molecular Devices and HeartBeat.bio announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery | Cardioid imaged on ImageXpress® Micro Confocal High-Content Imaging System As Cardioids represent better predictive models than cardiomyocytes or engineered spheroid models, this collaboration has the potential to considerably improve precl... |
| 24.05.2022 | Molecular Devices launches automated workcells for ELISA workflows | “The ability to reallocate resources from laborious tasks to more innovative work is critical for accelerating lifesaving research and bringing more therapeutics to market."
SAN JOSE, Calif. (PRWEB) May 24, 2022
Molecular Devices, LLC.... |
| 14.04.2022 | Molecular Devices launches new multi-mode microplate reader for academia and biotech laboratories | The budget-friendly SpectraMax® Mini Multi-Mode Microplate Reader maximizes productivity without compromising sensitivity or performance. We created the SpectraMax Mini reader for budget-conscious labs in need of a versatile, high-performin... |
| 12.04.2022 | Molecular Devices continues investment in Organoid Innovation Center adding cell engineering capabilities to automated 3D cell culture platform | The Organoid Innovation Center’s state-of-the-art methods and technologies now include automated workflows for synthetic biology, antibody discovery, and cell line development. We’re driving expanded capabilities for our customers as the in... |
| 07.02.2022 | Molecular Devices and Core Life Analytics collaborate, adding the StratoMineR cloud-powered data analytics software to Molecular Devices' high-content portfolio | Sophisticated Visualizations: Quickly produce and export sophisticated visualizations, such as hierarchical clustering visualizations, 3D scatter plots, spider plots, and heat maps. We’re thrilled to extend Core Life Analytics’ data analysi... |
| 03.02.2022 | Gold Sponsor Molecular Devices at Society for Laboratory Automation and Screening 2022 International Conference and Exhibition | Visit the company’s virtual booth at #SLAS2022 to connect with subject matter experts on demand, or explore the latest advancements in cell line development, 3D biology, and drug screening. From new product innovations to automating complex... |
| 24.01.2022 | Molecular Devices launches next-gen monoclonal verification imaging platform for automatic, day zero monoclonality assurance | The CloneSelect Imager FL is a next-generation fluorescent imaging solution for the assurance of monoclonality and automated confluence across diverse cell types. The CloneSelect® Imager FL joins a robust product portfolio designed to help ... |
| 20.01.2022 | Molecular Devices expands operations in Europe to meet growing demand for 3D biology research | Meeting the increasing demand in Europe has driven regional, double-digit growth for our business, and we are thrilled to commit more resources in support of our growing customer base.
SAN JOSE, Calif. (PRWEB) January 20, 2022
Molecular Dev... |
| 14.04.2021 | Molecular Devices opens Organoid Innovation Center | Organoid Innovation Center at Molecular Devices By allowing real-time feedback on 3D model development and providing greater confidence with standardized, more consistent protocols with precise timing of each step in the process, we’ve remo... |
| 25.01.2021 | Molecular Devices unveils next-generation imaging system with deep learning technology | Complete high-throughput imaging and analysis solution The ImageXpress Confocal HT.ai system with self-learning image analysis software follows a long history of life science solutions that empower our customers to solve their most challeng... |
| 25.01.2008 | Life sciences briefing: Friday, Jan. 25, 2008 | TODAY’S HEADLINES:
Health-info site HealthCentral Network pulls in $50M (paidContent)
BrightHeart Vet corrals $29M to acquire animal hospitals (release)
AviaraDx raises $8M for cancer diagnostics (peHUB)
Valor Medical aims for $15M for brai... |
